Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ATPase H+ transporting V1 subunit E1 pseudogene 1 (ATP6V1E1P1) is a human pseudogene, meaning it is a genomic locus that resembles a functional gene but is generally noncoding due to mutations or deletions, such as premature stop codons or frameshifts, which prevent it from producing a functional protein[3][5]. Pseudogenes may be transcribed, but their RNA does not encode a functional protein product. In rare cases, pseudogenes can act as regulators of their functional counterparts by competing for microRNA binding, but there is no evidence that ATP6V1E1P1 has such a role. ATP6V1E1P1 should not be considered a drug target or functional receptor, enzyme, transporter, or similar molecule[3][5]. Clarification: There is nothing explicitly “incorrect” about the name or description itself, but as a pseudogene, ATP6V1E1P1 is not considered a therapeutic target by conventional criteria. Therefore, `is_target` is false and `is_incorrect` is true for the purposes of curated drug discovery or pharmacological databases[3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATPase H+ transporting V1 subunit E1 pseudogene 1 (ATP6V1E1P1).